In the original article, there was a mistake in the third last patient in table 1 is listed to have the onconeuronal antibody "Am", which is corrected as "Amphiphysin". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

In addition, there was an error in the conclusion of the abstract, caused by a misunderstanding during the language translation. The original text is:

By contrast, cerebrospinal fluid analysis showed that serum autoantibodies and tumor markers, the function of crucial organs, electrophysiology, and radiological findings were not associated with a poor outcome.

A correction has been made to the corresponding text in the conclusion of the abstract:

By contrast, the results showed that cerebrospinal fluid analysis, serum autoantibodies and tumor markers, the function of crucial organs, electrophysiology, and radiological findings were not associated with a poor outcome.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
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